Global Health & Biotech Archives | Page 5 of 285 | Be Korea-savvy

Archive by category Global Health & Biotech

Boehringer Ingelheim acquires license from Kyowa Kirin aimed at developing a novel treatment for patients with autoimmune diseases

Boehringer Ingelheim acquires license from Kyowa Kirin aimed at developing a novel treatment for patients with autoimmune diseases

The licensed small molecule program aims to address significant unmet needs for autoimmune diseases.  Program adds to Boehringer’s pipeline and its commitment to deliver breakthrough therapies for patients with inflammatory diseases.  Ingelheim, Germany, and Tokyo, Japan, [October 30, 2025] – Boehringer Ingelheim and Kyowa Kirin Co., Ltd. (Kyowa Kirin, TSE:4151, President and COO: Abdul Mullick) today announced that Boehringer Ingelheim has licensed a pre-clinical program from Kyowa Kirin to develop [...]

Circle CVI Announces FDA Clearance for cvi42 | Plaque for Coronary Artery Disease Evaluation

Circle CVI Announces FDA Clearance for cvi42 | Plaque for Coronary Artery Disease Evaluation

CALGARY, Alberta, Oct. 29, 2025 (Korea Bizwire) – Circle Cardiovascular Imaging Inc. (Circle CVI), a global leader in cardiovascular imaging solutions, today announced that its cvi42 | Plaque solution has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) and is now available for clinical use in the United States. This innovative, AI-enabled [...]

Impulse Dynamics® Celebrates CMS National Coverage Determination for CCM® Therapy

Impulse Dynamics® Celebrates CMS National Coverage Determination for CCM® Therapy

Decision Immediately Expands Access to Heart Failure Therapy with National Coverage for More Than 66 Million[1] Patients MARLTON, N.J., Oct. 29, 2025 (Korea Bizwire) – Impulse Dynamics®, a global medical device company committed to improving the lives of people with heart failure (HF), announced today that the Centers for Medicare and Medicaid Services (CMS) issued [...]

Late-breaking iMODERN findings presented at TCT 2025 and published in the New England Journal of Medicine highlight new evidence to guide treatment choices for heart attack patients

Late-breaking iMODERN findings presented at TCT 2025 and published in the New England Journal of Medicine highlight new evidence to guide treatment choices for heart attack patients

October 29, 2025 3-Year data from the largest global trial to date using Class I, Level A iFR in heart attack patients shows treating additional stenoses in the same procedure showed no significant difference in major outcomes compared with waiting for follow-up Additional results from the ILIAS ANOCA study highlight the sustained benefits of physiology-guided [...]

Curia Releases 2024 Environmental, Social and Governance (ESG) Report

Curia Releases 2024 Environmental, Social and Governance (ESG) Report

ALBANY, N.Y., Oct. 28, 2025 (Korea Bizwire) – Curia Global, Inc. (Curia), a leading contract research, development and manufacturing organization, today announced the release of its third Environmental, Social and Governance (ESG) report. This latest report highlights the company’s new “C.U.R.I.A. Way” values—curiosity, urgency, respect, integrity and accountability—and how those values are woven into its [...]

Ascom, Dräger, and B. Braun Launch Silent ICU Solution, a Milestone in Patient-Centric Critical Care

Ascom, Dräger, and B. Braun Launch Silent ICU Solution, a Milestone in Patient-Centric Critical Care

Baar, Switzerland, 28 October 2025 Ascom, in partnership with Dräger and B. Braun, announces the launch of the Silent ICU solution, introduced at the ESICM LIVES 2025 Congress in Munich. This is a major milestone in critical care innovation and marks a new era in healing environment, patient safety, and workflow efficiency for intensive care [...]

CAPHRA announces “Asia Day” event to take place at The Good Cop 2.0 Conference Highlighting Harm Reduction in Asia Pacific

CAPHRA announces “Asia Day” event to take place at The Good Cop 2.0 Conference Highlighting Harm Reduction in Asia Pacific

MANILA, Philippines, Oct. 27, 2025 (Korea Bizwire) – The Coalition of Asia Pacific Tobacco Harm Reduction Advocates (CAPHRA) today announced Asia Day – The Good Cop 2.0, to be held on 19 November 2025, in parallel with the WHO’s COP11. Asia Day will bring together consumer advocates, public health experts, medical professionals, and policymakers to [...]

Philips introduces industry-first cath lab integration that automatically synchronizes pre-operative CT with C-arm movement, paving the way for CT-guided PCI

Philips introduces industry-first cath lab integration that automatically synchronizes pre-operative CT with C-arm movement, paving the way for CT-guided PCI

October 27, 2025                                                     New integration of Philips Advanced Visualization Workspace* with the Azurion image-guided therapy platform automatically synchronizes CT images with C-arm movement, supporting workflow efficiency and additional anatomical insights in PCI procedures1 San Francisco, USA and Amsterdam, The Netherlands – At the annual Transcatheter Cardiovascular Therapeutics (TCT 2025) meeting, Royal Philips (NYSE: PHG, AEX: PHIA), a global leader [...]

Curia Invests $4 Million to Enhance Sterile API Manufacturing

Curia Invests $4 Million to Enhance Sterile API Manufacturing

ALBANY, N.Y., Oct. 27, 2025 (Korea Bizwire) – Curia Global, Inc. (Curia), a leading global research, development and manufacturing organization, today announced the completion of a $4 million investment to upgrade its two API aseptic suites in Valladolid, Spain. The investment aligns with the latest EU GMP Annex 1 standards and reinforces Curia’s longstanding commitment [...]

KFSHRC Launches the First Facility for Gene and Cell Therapy Manufacturing in Saudi Arabia

KFSHRC Launches the First Facility for Gene and Cell Therapy Manufacturing in Saudi Arabia

RIYADH, Saudi Arabia, Oct. 27, 2025 (Korea Bizwire) – King Faisal Specialist Hospital and Research Centre said it will open Saudi Arabia’s first facility for manufacturing genetic and cellular therapies by late 2025, a project designed to give thousands of patients access to advanced treatments at home, reduce the cost of care by an estimated [...]